CRYSTALLIZATION AND THERMAL EXPANSION CHARACTERISTICS OF In2O3-CONTAINING LITHIUM IRON SILICATE-DIOPSIDE GLASSES

The crystallization characteristics of glasses based on lithium iron silicate (LiFeSi2O6)-diopside (CaMgSi2O6) composition with addition of Al2O3 at the expense of Fe2O3 were described. The effect of LiInSi2O6/CaMgSi2O6 replacements was also investigated. The thermal treatment, the crystal phases, and the micro-structural properties of (LiFeSi2O6–CaMgSi2O6) glasses, replacing partial Fe2O3 with Al2O3 and partial CaMgSi2O6 with LiInSi2O6, have been studied by a differential thermal analysis, an X-ray diffraction, and a scanning electron microscopy. The glasses show the intense uniform bulkcrystallization with the fine grained microstructure by increasing the replacement of Al2O3/Fe2O3 and LiInSi2O6/CaMgSi2O6. The crystallizing phases of Ca(Fe,Mg)(SiO3)2, a-LiFe5O8, Li2SiO3, a-SiO2 and CaMgSi2O6 are mostly formed together, in most case, with Li0.6Al0.6Si2.4O6, β-eucryptite solid solution, LiInSi2O6, In2Si2O7, and LiFeSi2O6. The Al2O3 partial replacement increases the transformation temperature (Tg) and softening one (Ts) for the glasses and the glass-ceramics, and decreases the thermal expansion coefficient (a-value) for the glasses. The LiInSi2O6 partial replacement decreases Tg and Ts and increases the a-value for the glasses, while the Al2O3 and LiInSi2O6 partial replacements decrease the a-value for the glassceramics. The crystallization characters of the glasses are correlated to the internal structure, as well as role played by the glass-forming cations. However, the one of the glass-ceramics are mainly attributed to the crystalline phases formed in the material

ESTIMATES OF GENETIC COMPONENTS, PREDICTION AND GENETIC CORRELATION IN WHEAT (TRITICUM AESTIVUM,L.) USING NORTH CAROLINA DESIGN III

North Carolina Design III was used to estimate gene effects in bread wheat crosses. Twelve Egyptian bread wheat genotypes i.e. Sakha 69, Sakha 8, Gemmeiza 1, Gemmeiza 3, Gemmeiza 7, Giza 160, , Giza 162, Giza 164, Giza 165, Sids 1, Sids 3 and Sids  4, each was crossed back to testers, high performing (Gemmeiza 9) and low performing parent (Sakha 92) during three winter successive seasons i.e. 2002/2003, 2003/2004 and 2004/2005, to study; heading date (days) plant height (cm), flag leaf length (cm) flag leaf width (cm), flag leaf area (cm)2, extrusion length (cm), number of spikelets/spike, spike grain weight (g.), number of spikes/plant, number of grains/spike, 1000-grain weight (g.) and grain yield/plant (g.) characters. Results indicated that epistasis played great role in the inheritance of all studied characters except number of spikes/plant. Additive(D)and dominance(H) genetic variances were significant in all studied characters except number of spikes/plant and number of grains/spike. The additive genetic variance was more than dominance for heading date, plant height, flag leaf length, flag leaf width, extrusion length, spike length and 1000- grain weight. The ratio of (H./D) 0.5 was less than one for these characters but for the remaining characters the dominance genetic variance was more than additive. The values of(F) indicated that dominance was unidirectional for flag leaf length and flag leaf area, whereas it was ambidirectional for the remaining characters Prediction results revealed that it could be possible to derive reasonable proportion of new recombinants which are falling out side parental range for heading date, flag leaf length, flag leaf width, spike length, number of spikelets/spike, number of spikes/plant, 1000- grain weight and grain yield/plant. Genetic correlation indicated that additive, dominance and epistasis gene effects controlling grain yield/plant and spike grain weight, number of spikes/plant, number of grains/spike, 1000- grain weight, were signifant, suggesting common genetic pool or pleiotropy. Thus, selection based on additive genetic correlation indicated that indirect selection via, spike grain weight, number of spikes/plant, number of grains/spike and 1000- grain weight would be effective and enhance its importance as selection criteria

Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached$8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total,$40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this,$13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and$1.4 billion was repurposed from existing health projects. $3.1 billion (22.4$2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7$1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

Search for leptophobic Z ' bosons decaying into four-lepton final states in proton-proton collisions at root s=8 TeV

Peer reviewe

Search for high-mass diphoton resonances in proton-proton collisions at 13 TeV and combination with 8 TeV search

Peer reviewe

Measurement of the mass difference between top quark and antiquark in pp collisions at root s=8 TeV

Peer reviewe

Search for neutral resonances decaying into a Z boson and a pair of b jets or τ leptons

A search is performed for a new resonance decaying into a lighter resonance and a Z boson. Two channels are studied, targeting the decay of the lighter resonance into either a pair of oppositely charged τ leptons or a bb‾ pair. The Z boson is identified via its decays to electrons or muons. The search exploits data collected by the CMS experiment at a centre-of-mass energy of 8 TeV, corresponding to an integrated luminosity of 19.8 fb −1 . No significant deviations are observed from the standard model expectation and limits are set on production cross sections and parameters of two-Higgs-doublet models

Performance of reconstruction and identification of τ leptons decaying to hadrons and vτ in pp collisions at √s=13 TeV

The algorithm developed by the CMS Collaboration to reconstruct and identify τ leptons produced in proton-proton collisions at √s=7 and 8 TeV, via their decays to hadrons and a neutrino, has been significantly improved. The changes include a revised reconstruction of π⁰ candidates, and improvements in multivariate discriminants to separate τ leptons from jets and electrons. The algorithm is extended to reconstruct τ leptons in highly Lorentz-boosted pair production, and in the high-level trigger. The performance of the algorithm is studied using proton-proton collisions recorded during 2016 at √s=13 TeV, corresponding to an integrated luminosity of 35.9 fb¯¹. The performance is evaluated in terms of the efficiency for a genuine τ lepton to pass the identification criteria and of the probabilities for jets, electrons, and muons to be misidentified as τ leptons. The results are found to be very close to those expected from Monte Carlo simulation

Search for vectorlike charge 2/3 T quarks in proton-proton collisions at root(s)=8 TeV

Peer reviewe